You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelin-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Hypertension, Adolescent Obesity Trial in Surabaya

Not yet recruiting
  • Obesity
  • +2 more
    • Surabaya, Jawa Timur, Indonesia
      RS Bhayangkara Surabaya
    Jul 16, 2023

    Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

    Recruiting
    • Cardiac Allograft Vasculopathy
    • Los Angeles, California
      Ronald Regan UCLA Medical Center
    May 9, 2022

    Preeclampsia, Microvascular Function Trial (Acetylcholine, Endothelin-1)

    Not yet recruiting
    • Preeclampsia
    • Microvascular Function
    • (no location specified)
    Dec 15, 2022

    Heart Failure Trial in Salt Lake City (BQ-123)

    Completed
    Has Results
    • Heart Failure
    • Salt Lake City, Utah
      VA Salt Lake City Health Care System, Salt Lake City, UT
    Dec 17, 2021

    Type 1 Diabetes Trial in Augusta (Resveratrol, Placebo)

    Recruiting
    • Type 1 Diabetes
    • Augusta, Georgia
      Augusta University/Georgia Prevention Institute/ Laboratory of I
    Jul 18, 2022

    Premature Infants With Bronchopulmonary Dysplasia

    Completed
    • Bronchopulmonary Dysplasia (BPD)
    • Hypertension, Pulmonary
      • Mountain View, California
      • +1 more
      Sep 23, 2021

      Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete

      Recruiting
      • Acute Myeloid Leukemia, Adult
      • +2 more
      • History taking
      • +14 more
      • Samara, Samara Region, Russian Federation
        Clinics of the Samara Medical University
      Jan 26, 2023

      Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

      Completed
      • Cardiac Failure
        • Wetzikon, Switzerland
          GZO Regional Health Center
        Jul 13, 2021

        Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

        Not yet recruiting
        • Type 1 Diabetes Mellitus With Diabetic Nephropathy
        • Aurora, Colorado
        • +6 more
        Oct 2, 2023

        Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

        Enrolling by invitation
        • Chronic Kidney Diseases
        • Aurora, Colorado
        • +5 more
        Oct 18, 2022

        Resistant Hypertension Trial (Bosentan, Placebo)

        Not yet recruiting
        • Resistant Hypertension
        • (no location specified)
        May 13, 2020

        ET1 Concentration, Metabolic Pathway Activation, and Pulmonary

        Recruiting
        • Single-ventricle
        • +4 more
        • Research Blood Sampling
        • Denver, Colorado
          Children's Hospital Colorado
        Aug 16, 2021

        Sickle Cell Anemia Trial in Augusta (Ambrisentan, Placebo)

        Completed
        • Sickle Cell Anemia
        • Augusta, Georgia
          Augusta University
        Apr 1, 2020

        Migraine With Aura Trial in Glostrup (Endothelin-1, Placebo)

        Unknown status
        • Migraine With Aura
        • Endothelin-1
        • Placebo
        • Glostrup, Denmark
          Danish Headache Center
        Dec 10, 2019

        Hypertension Trial in Augusta (Bosentan, Placebo)

        Active, not recruiting
        • Hypertension
        • Augusta, Georgia
          Georgia Regents University
        Jul 18, 2022

        ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

        Recruiting
        • ANCA Associated Vasculitis
        • +2 more
        • Edinburgh, United Kingdom
          Centre for Cardiovascular Science, Queen's Medical Research Inst
        Jan 26, 2023

        Kidney Failure, Acute Trial in Haifa (Ambrisentan 10 MG)

        Unknown status
        • Kidney Failure, Acute
        • Ambrisentan 10 MG
        • Haifa, Israel
        • +1 more
        Jun 24, 2020

        Ocular Physiology, Optic Disk, Regional Blood Flow Trial in Vienna (drug, device, procedure)

        Withdrawn
        • Ocular Physiology
        • +2 more
        • NG-monomethyl-L-arginine (L-NMMA)
        • +6 more
        • Vienna, Austria
          Department of Clinical Pharmacology, Medical University of Vienn
        Aug 13, 2019

        Hypertension Trial in Augusta (Candesartan, Placebo)

        Active, not recruiting
        • Hypertension
        • Augusta, Georgia
          Georgia Prevention Institute/ Laboratory of Integrative and Exer
        Jul 18, 2022

        Cardiovascular Risk Factor Trial in Newark (No to Low Endogenous Estrogen, Estradiol)

        Recruiting
        • Cardiovascular Risk Factor
        • No to Low Endogenous Estrogen
        • Estradiol
        • Newark, Delaware
          University of Delaware
        Oct 14, 2021

        Hypertension, Cardiovascular Risk Factor Trial in Taipei (Resistance exercise training)

        Completed
        • Hypertension
        • Cardiovascular Risk Factor
        • Resistance exercise training
        • Taipei, Taiwan
          National Taiwan University
        Dec 21, 2022

        COVID-19, Endothelial Function, Diastolic Dysfunction Trial in Moscow (Portable cardiac monitor "CardioQvark", Cardiorespiratory

        Recruiting
        • COVID-19
        • +5 more
        • Portable cardiac monitor "CardioQvark"
        • +2 more
        • Moscow, Russian Federation
          I.M. Sechenov First Moscow State Medical University (Sechenov Un
        Nov 5, 2022

        Inflammation and of Pro-thrombotic State in Hospital Shift and

        Recruiting
        • Shift-Work Related Sleep Disturbance
        • +3 more
        • Tests for markers of inflammation and activated hemostasis
        • Milan, Italy
          Centro Cardiologico Monzino
        Mar 7, 2023

        Coronary Disease Trial in Zhengzhou (remote ischemic preconditioning (RIPC))

        Recruiting
        • Coronary Disease
        • remote ischemic preconditioning （RIPC）
        • Zhengzhou, Henan, China
          Fuwai central China cardiovascular Hospital
        Mar 29, 2022

        End Stage Renal Disease Trial in Cairo (Black Seed Oil, Placebo)

        Active, not recruiting
        • End Stage Renal Disease
        • Black Seed Oil
        • Placebo
        • Cairo, Egypt
          Ain Shams University Hospital
        Apr 8, 2023